✦ LIBER ✦

533 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF TENOFOVIR DF IN ADOLESCENTS WITH CHRONIC HEPATITIS B

✍ Scribed by K.F. Murray; L. Szenborn; J. Wysocki; S. Rossi; A.C. Corsa; P. Dinh; J.G. McHutchison; P.S. Pang; L.M. Luminos; M. Pawlowska; J. Mizerski

Book ID: 117380745
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(12)60546-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, placebo-controlled trial of

Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

✍ Karen F. Murray; Leszek Szenborn; Jacek Wysocki; Stephen Rossi; Amoreena C. Cors 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 526 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C

✍ Hideki Ueno; Tosiya Sato; Seiichiro Yamamoto; Katsuaki Tanaka; Shinichi Ohkawa; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Prospective, randomized controlled trial

Prospective, randomized controlled trial of interferon-α in children with chronic hepatitis B

✍ Mercedes Ruiz-Moreno; Maria José Rua; Josefina Molina; Gloria Moraleda; Alberto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Thirty-six children with chronic hepatitis B were entered into a randomized controlled trial of recombinant human interferon-a. All patients had hepatitis B virus DNA and increased levels of aminotransferases in serum for at least 1 yr. Twelve children received 10 MU of interferon-a 2b/m2 body surfa

A randomized controlled trial of thymope

A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B

✍ Giovanna Fattovich; Giuliano Giustina; Alfredo Alberti; Maria Guido; Patrizia Po 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 470 KB

Mo1833 Efficacy and Safety of Entecavir

Mo1833 Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Chronic Hepatitis B Patients: A Randomized Controlled Trial

✍ Sriprayoon, Tassanee; Lueangarun, Saoraya; Suwanwela, Charas; Pattaranutaporn, P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Interferon-α and zidovudine combination

Interferon-α and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo-controlled trial

✍ Harry L. A. Janssen; Luuk Berk; Rudolf A. Heijtink; Fiebo J. W. Ten Kate; Solko 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Interferon-a therapy leads to HBeAg seroconversion in only one third of patients with chronic hepatitis B. In an attempt to increase the seroconversion rate, we investigated the combination of interferon-a and zidovudine in a subset of patients with presumably low response rates for interferon-a mon